Dexa/Freakonomics Radio

Published Dec 12, 2024

615. Is Ozempic as Magical as It Sounds? | Freakonomics Radio

Stephen Dubner and Ezekiel Emanuel delve into the revolutionary potential of GLP-1 drugs like Ozempic in treating diabetes and obesity, while addressing ethical issues in healthcare access, innovative economic models for drug affordability, and the future of telemedicine and AI in transforming medical practices.

Episode Highlights

Topics covered

Questions from this episode

- Explain more about the pros and cons of Ozempic
  Asked by 658 people
- How will AI impact humanity's future?
  Asked by 220 people
- Tell me something about artificial intelligence
  Asked by 173 people
- What are some of the amazing things that AI can do?
  Asked by 164 people
- What role can AI play in various fields?
  Asked by 137 people
- Are there any alternative medications to Ozempic for weight loss?
  Asked by 137 people
- What has been said about artificial intelligence?
  Asked by 129 people
- What are the implications for artificial intelligence?
  Asked by 113 people
- What can we expect in the future of AI?
  Asked by 106 people
- What is the future of AI?
  Asked by 103 people
- Can I get a medical opinion on Ozempic?
  Asked by 95 people
- What's the potential impact of AI in the future?
  Asked by 91 people
- What are the issues with the current healthcare system?
  Asked by 88 people
- What opportunities does AI open up?
  Asked by 81 people
- Can artificial intelligence transform our lives?
  Asked by 79 people

Episode Highlights

Related Episodes

EXTRA: The Opioid Tragedy — How We Got Here | Freakonomics Radio
Answers 383 questions
590. Can $55 Billion End the Opioid Epidemic? | Freakonomics Radio
Answers 383 questions
How to Fix the Hot Mess of U.S. Healthcare | Freakonomics Radio | Episode 456
Answers 383 questions
589. Why Has the Opioid Crisis Lasted So Long? | Freakonomics Radio
Answers 383 questions
570. Is Gynecology the Best Innovation Ever? | Freakonomics Radio
Answers 383 questions
How to Fix the Incentives in Cancer Research | Freakonomics Radio | Episode 449
Answers 383 questions
Is Dialysis a Test Case of Medicare for All? | Freakonomics Radio | Episode 457
Answers 383 questions
Policymaking Is Not a Science (Yet) | Freakonomics Radio | Episode 405
Answers 383 questions
602. Is Screen Time as Poisonous as We Think? | Freakonomics Radio
Answers 383 questions
592. How to Make the Coolest Show on Broadway | Freakonomics Radio
Answers 383 questions
568. Why Are People So Mad at Michael Lewis? | Freakonomics Radio
Answers 383 questions
“Insurance Is Sexy.” (Discuss.) | Freakonomics Radio | Episode 537
Answers 383 questions
562. How to Succeed at Failing, Part 2: Life and Death | Freakonomics Radio
Answers 383 questions
How Are Psychedelics and Other Party Drugs Changing Psychiatry? | Freakonomics Radio | Episode 433
Answers 383 questions
593. You Can Make a Killing, but Not a Living | Freakonomics Radio
Answers 383 questions